Robert Thomas Freeman Sells 30,500 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 30,500 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $13.42, for a total value of $409,310.00. Following the transaction, the chief financial officer now directly owns 92,929 shares of the company’s stock, valued at approximately $1,247,107.18. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Thursday, October 31st, Robert Thomas Freeman sold 36,197 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.04, for a total value of $435,811.88.
• On Tuesday, October 29th, Robert Thomas Freeman sold 4,483 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.01, for a total value of $53,840.83.
• On Monday, October 14th, Robert Thomas Freeman sold 30,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $11.50, for a total value of $350,750.00.
• On Tuesday, October 8th, Robert Thomas Freeman sold 39,320 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.04, for a total value of $473,412.80.
• On Tuesday, October 1st, Robert Thomas Freeman sold 21,375 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.66, for a total value of $227,857.50.
• On Friday, September 13th, Robert Thomas Freeman sold 14,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.00, for a total value of $174,000.00.
• On Wednesday, September 11th, Robert Thomas Freeman sold 8,561 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total value of $85,695.61.
• On Wednesday, September 4th, Robert Thomas Freeman sold 1,650 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.00, for a total value of $16,500.00.

Alignment Healthcare Stock Down 2.9 %

Shares of NASDAQ ALHC opened at $12.78 on Thursday. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $14.25. The stock has a market capitalization of $2.45 billion, a P/E ratio of -16.60 and a beta of 1.45. The stock’s fifty day moving average is $11.49 and its 200 day moving average is $9.28.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, meeting the consensus estimate of ($0.14). The business had revenue of $692.43 million for the quarter, compared to analyst estimates of $662.11 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. Alignment Healthcare’s revenue was up 51.6% compared to the same quarter last year. During the same period last year, the firm posted ($0.19) earnings per share. Sell-side analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Institutional Trading of Alignment Healthcare

Hedge funds have recently made changes to their positions in the company. Virtu Financial LLC acquired a new stake in shares of Alignment Healthcare during the first quarter valued at about $57,000. nVerses Capital LLC acquired a new stake in shares of Alignment Healthcare during the third quarter valued at about $95,000. Principal Financial Group Inc. boosted its stake in shares of Alignment Healthcare by 18.1% during the second quarter. Principal Financial Group Inc. now owns 13,521 shares of the company’s stock valued at $106,000 after purchasing an additional 2,077 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Alignment Healthcare during the third quarter valued at about $131,000. Finally, Creative Planning boosted its stake in shares of Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after purchasing an additional 2,072 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on ALHC shares. UBS Group increased their price target on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research note on Wednesday, October 30th. Barclays increased their price objective on Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 30th. Stifel Nicolaus increased their price objective on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. Robert W. Baird increased their price objective on Alignment Healthcare from $10.00 to $11.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 14th. Finally, Piper Sandler reiterated an “overweight” rating and set a $10.00 price objective (up previously from $8.00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $10.33.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.